EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
7.4.2.5 | Homo sapiens | - |
- |
- |
7.4.2.5 | Mus musculus | - |
- |
- |
7.4.2.5 | Rattus norvegicus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
7.4.2.5 | biliary duct | - |
Mus musculus | - |
7.4.2.5 | intestine | - |
Mus musculus | - |
7.4.2.5 | intestine | - |
Homo sapiens | - |
7.4.2.5 | intestine | - |
Rattus norvegicus | - |
7.4.2.5 | kidney | - |
Mus musculus | - |
7.4.2.5 | nasal epithelium | - |
Mus musculus | - |
7.4.2.5 | prostate cancer cell | - |
Mus musculus | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
7.4.2.5 | ATP + H2O + cefadroxil/in | preferable substrate | Mus musculus | ADP + phosphate + cefadroxil/out | - |
? | |
7.4.2.5 | ATP + H2O + cefadroxil/in | preferable substrate | Homo sapiens | ADP + phosphate + cefadroxil/out | - |
? | |
7.4.2.5 | ATP + H2O + cefadroxil/in | preferable substrate | Rattus norvegicus | ADP + phosphate + cefadroxil/out | - |
? | |
7.4.2.5 | ATP + H2O + D-phenylglycine-L-Dopa/in | - |
Mus musculus | ADP + phosphate + D-phenylglycine-L-Dopa/out | - |
? | |
7.4.2.5 | ATP + H2O + D-phenylglycine-L-Dopa/in | - |
Homo sapiens | ADP + phosphate + D-phenylglycine-L-Dopa/out | - |
? | |
7.4.2.5 | ATP + H2O + D-phenylglycine-L-Dopa/in | - |
Rattus norvegicus | ADP + phosphate + D-phenylglycine-L-Dopa/out | - |
? | |
7.4.2.5 | ATP + H2O + delta-aminolevulinic acid/in | - |
Mus musculus | ADP + phosphate + delta-aminolevulinic acid/out | - |
? | |
7.4.2.5 | ATP + H2O + delta-aminolevulinic acid/in | - |
Homo sapiens | ADP + phosphate + delta-aminolevulinic acid/out | - |
? | |
7.4.2.5 | ATP + H2O + delta-aminolevulinic acid/in | - |
Rattus norvegicus | ADP + phosphate + delta-aminolevulinic acid/out | - |
? | |
7.4.2.5 | ATP + H2O + guanidine oseltamivir carboxylate-L-Val/in | - |
Mus musculus | ADP + phosphate + guanidine oseltamivir carboxylate-L-Val/out | - |
? | |
7.4.2.5 | ATP + H2O + guanidine oseltamivir carboxylate-L-Val/in | - |
Homo sapiens | ADP + phosphate + guanidine oseltamivir carboxylate-L-Val/out | - |
? | |
7.4.2.5 | ATP + H2O + guanidine oseltamivir carboxylate-L-Val/in | - |
Rattus norvegicus | ADP + phosphate + guanidine oseltamivir carboxylate-L-Val/out | - |
? | |
7.4.2.5 | ATP + H2O + JBP485/in | JBP485 is cyclo-trans-4-L-hydroxyprolyl-L-serine | Mus musculus | ADP + phosphate + JBP485/out | - |
? | |
7.4.2.5 | ATP + H2O + JBP485/in | JBP485 is cyclo-trans-4-L-hydroxyprolyl-L-serine | Homo sapiens | ADP + phosphate + JBP485/out | - |
? | |
7.4.2.5 | ATP + H2O + JBP485/in | JBP485 is cyclo-trans-4-L-hydroxyprolyl-L-serine | Rattus norvegicus | ADP + phosphate + JBP485/out | - |
? | |
7.4.2.5 | ATP + H2O + L-Val-didanosine/in | didanosine is also named Videx or 5'-O-2'-3'-dideoxydidanosine | Mus musculus | ADP + phosphate + L-Val-didanosine/out | - |
? | |
7.4.2.5 | ATP + H2O + L-Val-didanosine/in | didanosine is also named Videx or 5'-O-2'-3'-dideoxydidanosine | Homo sapiens | ADP + phosphate + L-Val-didanosine/out | - |
? | |
7.4.2.5 | ATP + H2O + L-Val-didanosine/in | didanosine is also named Videx or 5'-O-2'-3'-dideoxydidanosine | Rattus norvegicus | ADP + phosphate + L-Val-didanosine/out | - |
? | |
7.4.2.5 | ATP + H2O + NP-647/in | NP-647 is L-pGlu-(2-propyl)-L-His-L-ProNH2 | Mus musculus | ADP + phosphate + NP-647/out | - |
? | |
7.4.2.5 | ATP + H2O + NP-647/in | NP-647 is L-pGlu-(2-propyl)-L-His-L-ProNH2 | Homo sapiens | ADP + phosphate + NP-647/out | - |
? | |
7.4.2.5 | ATP + H2O + NP-647/in | NP-647 is L-pGlu-(2-propyl)-L-His-L-ProNH2 | Rattus norvegicus | ADP + phosphate + NP-647/out | - |
? | |
7.4.2.5 | ATP + H2O + valacyclovir/in | - |
Mus musculus | ADP + phosphate + valacyclovir/out | - |
? | |
7.4.2.5 | ATP + H2O + valacyclovir/in | - |
Homo sapiens | ADP + phosphate + valacyclovir/out | - |
? | |
7.4.2.5 | ATP + H2O + valacyclovir/in | - |
Rattus norvegicus | ADP + phosphate + valacyclovir/out | - |
? | |
7.4.2.5 | ATP + H2O + Zan-L-Val/in | - |
Mus musculus | ADP + phosphate + Zan-L-Val/out | - |
? | |
7.4.2.5 | ATP + H2O + Zan-L-Val/in | - |
Homo sapiens | ADP + phosphate + Zan-L-Val/out | - |
? | |
7.4.2.5 | ATP + H2O + Zan-L-Val/in | - |
Rattus norvegicus | ADP + phosphate + Zan-L-Val/out | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
7.4.2.5 | PepT1 | - |
Mus musculus |
7.4.2.5 | PepT1 | - |
Homo sapiens |
7.4.2.5 | PepT1 | - |
Rattus norvegicus |
EC Number | General Information | Comment | Organism |
---|---|---|---|
7.4.2.5 | malfunction | enzyme ablation results in 3-5fold reduction in the in vivo rate and extent of valacyclovir absorption | Mus musculus |